Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes

Magdalena Julia Dabrowska(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Finn Skou Pedersen(Aarhus University), Hans Erik Johnsen(Herlev Hospital), Matthias Wabl(University of California, San Francisco), Ditte Møller Ejegod(Aarhus University), Louise Berkhoudt Lassen(Aarhus University)
Leukemia Research
July 27, 2013
10.1016/j.leukres.2013.04.012
Cited by 3

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
|Blood|2009|390
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
|Leukemia|2015|256